Treatment of visceral leishmaniasis (kala-azar) with aminosidine (= paromomycin)-antimonial combinations, a pilot study in Bihar, India

Trans R Soc Trop Med Hyg. 1992 Nov-Dec;86(6):615-6. doi: 10.1016/0035-9203(92)90150-b.

Abstract

A 20 d drug regimen of aminosidine (= paromomycin) at 12 mg/kg/d in combination with sodium stibogluconate at 20 mg/kg/d proved efficacious and well-tolerated in patients with visceral leishmaniasis in the State of Bihar, India. Eighteen of 22 evaluable patients achieved an ultimate cure. The remaining 4 patients, although not cleared of parasites, had their parasite grade reduced and also improved clinically. This confirms prior findings in Kenyan patients with kala-azar, and indicates that this regimen is a valid alternative to antimonial compounds alone in the State of Bihar, where cases of kala-azar not responding to antimonial drugs and intolerant of pentamidine are increasingly recorded.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antimony Sodium Gluconate / therapeutic use*
  • Child
  • Child, Preschool
  • Drug Therapy, Combination
  • Female
  • Humans
  • Infant
  • Leishmaniasis, Visceral / drug therapy*
  • Male
  • Middle Aged
  • Paromomycin / therapeutic use*
  • Pilot Projects

Substances

  • Paromomycin
  • Antimony Sodium Gluconate